Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ijantimicag.2020.106051 http://scihub22266oqcxt.onion/10.1016/j.ijantimicag.2020.106051 32534186!7286278!32534186     free     free     free       Int+J+Antimicrob+Agents 2020 ; 56 (2): 106051 Nephropedia Template TP {{tp|p=32534186|t=2020. Procalcitonin levels in COVID-19 patients |pdf=|usr=}}{{32534186}} gab.com Text Procalcitonin levels in COVID-19 patients JO: Int J Antimicrob Agents http://www.kidney.de/pget.php?&tw=1&pmid=32534186 #FOAvip Coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been declared a pandemic. This study analysed 95 SARS-CoV-2-infected patients, including 62 moderate COVID-19 patients, 21 severe COVID-19 patients and 12 critical COVID-19 patients (6 patients died, all critical). The results showed that the mean serum procalcitonin (PCT) levels were over four times higher in severe patients than in moderate patients and were over eight times higher in critical patients than in moderate patients. For discharged patients, both high-normal PCT levels and abnormal PCT levels decreased during recovery. However, in death cases, serum levels of PCT increased as the disease worsened. We demonstrate that PCT may be an indicator of disease severity in COVID-19 and may contribute to determining the severity of patients infected with SARS-CoV-2. Moreover, serial PCT measurements may be useful in predicting the prognosis. Twit Text FOAVip Procalcitonin levels in COVID-19 patients ????Int J Antimicrob Agents http://www.kidney.de/pget.php?&tw=1&pmid=32534186 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32534186 #FOAvip English Wikipedia <ref>{{Cite pmid|32534186}}</ref> Procalcitonin levels in COVID-19 patients #MMPMID32534186 Hu R; Han C; Pei S; Yin M; Chen X Int J Antimicrob Agents 2020[Aug]; 56 (2): 106051 PMID32534186show ga Coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been declared a pandemic. This study analysed 95 SARS-CoV-2-infected patients, including 62 moderate COVID-19 patients, 21 severe COVID-19 patients and 12 critical COVID-19 patients (6 patients died, all critical). The results showed that the mean serum procalcitonin (PCT) levels were over four times higher in severe patients than in moderate patients and were over eight times higher in critical patients than in moderate patients. For discharged patients, both high-normal PCT levels and abnormal PCT levels decreased during recovery. However, in death cases, serum levels of PCT increased as the disease worsened. We demonstrate that PCT may be an indicator of disease severity in COVID-19 and may contribute to determining the severity of patients infected with SARS-CoV-2. Moreover, serial PCT measurements may be useful in predicting the prognosis. |Betacoronavirus/*isolation & purification[MESH] |COVID-19[MESH] |Coronavirus Infections/*metabolism/virology[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/*metabolism/virology[MESH] |Procalcitonin/*metabolism[MESH] |Retrospective Studies[MESH] |SARS-CoV-2[MESH]Procalcitonin levels in COVID-19 patients (epmc).pdf DeepDyve Pubget Overpricing